Finance & Capital Management

Hikma intros dobutamine injection
The injection is indicated when parenteral therapy is necessary for inotropic support in the short-term treatment of adults with cardiac decompensation due to specific factors.
Kroger posts solid Q1 results, reaffirms 2023 guidance
Kroger's total sales were $45.2 billion in the first quarter, compared to $44.6 billion for the same period last year.

Sun Pharma approves appointment of 2 board directors

Sun Pharma's board of directors recently approved the appointment of Rolf Hoffmann and Aalok Shanghvi to its board.
CVS Health finalizes previously announced global opioid settlement agreement

This settlement will resolve opioid-related claims and litigation by states, territories and political subdivisions such as counties and cities in the United States.
Teva to pay Kentucky $1.407M to settle state's price fixing claims

Teva will pay the state $1.407 million, and the state will dismiss all of its claims against Teva and its affiliates once payment has been made.
Walgreens Boots Alliance reaches $500M opioid settlement with New Mexico

The settlement is reportedly the largest obtained by New Mexico against a single company over opioids.
Alvotech, Teva secure U.S. license date for proposed Stelara biosimilar

According to the settlement agreement, AVT04 (ustekinumab) can be marketed in the United States, subject to regulatory approval, no later than Feb. 21, 2025.
Giant, customers raise $1.46M to grow food system sustainability

The campaign, now in its third year, has raised more than $5.6 million to grow health and sustainability initiatives.
Walgreens Boots Alliance sells remaining shares of Option Care Health

Walgreens Boots Alliance sold its remaining shares of Option Care Health for approximately $330 million.
NCPA survey: Majority of independents concerned about prepping for DIR hangover

The survey also reveals ongoing drug shortages and staffing challenges.

Finance & Capital Management

Hikma intros dobutamine injection

Kroger posts solid Q1 results, reaffirms 2023 guidance

Sun Pharma approves appointment of 2 board directors

CVS Health finalizes previously announced global opioid settlement agreement

Teva to pay Kentucky $1.407M to settle state's price fixing claims

Walgreens Boots Alliance reaches $500M opioid settlement with New Mexico

Alvotech, Teva secure U.S. license date for proposed Stelara biosimilar

Giant, customers raise $1.46M to grow food system sustainability

Walgreens Boots Alliance sells remaining shares of Option Care Health

NCPA survey: Majority of independents concerned about prepping for DIR hangover